NASDAQ, LGND - Ligand Pharm
Caution: This discussion and analysis may contain predictions, estimates and
other forward-looking statements that involve a number of risks and
uncertainties, including those discussed in Item 1A. ?Risk Factors.? This
outlook represents our current judgment on the future direction of our business.
These statements include those related to our AVINZA royalty revenues, product
returns, and product development. Actual events or results may differ materially
from Ligand?s expectations. For example, there can be no assurance that our
revenues or expenses will meet any expectations or follow any trend(s), that we
will be able to retain our key employees or that we will be able to enter into
any strategic partnerships or other transactions. ...
Read SEC Filing on NASDAQ.com »